562-74-3
Chemical Structure
Terpinen-4-ol
Synonym(s): 4-Carvomenthenol
- CAS No.: 562-74-3
- Formula:C10H18O
- Molecular Weight:154.25
IUPAC Name: 1-isopropyl-4-methylcyclohex-3-en-1-ol
InChIKey: WRYLYDPHFGVWKC-UHFFFAOYSA-N
SMILES: CC1=CCC(C(C)C)(O)CC1
Biological Activity: Terpinen-4-ol (4-Carvomenthenol) is a naturally occurring monoterpene, and can be extracted from a variety of aromatic plants. Terpinen-4-ol is a potent bactericidal agent which possess antifungal , anti-inflammatory and antitumor properties as well, suggesting Terpinen-4-ol to be used for relevant research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Terpinen-4-ol | 98.40% | Terpinen-4-ol (4-Carvomenthenol) is a naturally occurring monoterpene, and can be extracted from a variety of aromatic plants. Terpinen-4-ol is a potent bactericidal agent which possess antifungal , anti-inflammatory and antitumor properties as well, suggesting Terpinen-4-ol to be used for relevant research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Terpinen-4-ol (Standard) | ≥98% | Terpinen-4-ol (Standard) is the analytical standard of Terpinen-4-ol. This product is intended for research and analytical applications. Terpinen-4-ol (4-Carvomenthenol) is a naturally occurring monoterpene, and can be extracted from a variety of aromatic plants. Terpinen-4-ol is a potent bactericidal agent which possess antifungal , anti-inflammatory and antitumor properties as well, suggesting Terpinen-4-ol to be used for relevant research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Hart PH, et al. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000 Nov;49(11):619-26. [Content Brief]
- [2]. Shapira S, et al. Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers. PLoS One. 2016 Jun 8;11(6):e0156540. [Content Brief]